Target intelligence / Profile preview

Cirhin (UTP4)

Target
UTP4
Molecular classification
WD repeat-containing protein, SSU processome component, Other
01

Overview

Cirhin is a WD40 repeat-containing protein encoded by the UTP4 (formerly CIRH1A) gene, primarily localized in the nucleolus [UniProt: P58061]. It functions as a critical component of the t-UTP subcomplex within the small subunit (SSU) processome, which is essential for the initial stages of pre-ribosomal RNA processing and ribosome biogenesis [PubMed: 20439433]. This complex is required for the transcription of rDNA and the subsequent processing of the 47S pre-rRNA [PubMed: 12145751]. Mutations in the Cirhin gene, specifically the R565W substitution, are the primary cause of North American Indian Childhood Cirrhosis (NAIC), an autosomal recessive intrahepatic cholestasis [OMIM: 607456]. NAIC is characterized by neonatal jaundice, progressing to biliary cirrhosis and portal hypertension in childhood [PubMed: 12145751]. While Cirhin is not currently a target for any approved pharmacological agents, its role in ribosome assembly makes it a subject of study in genetic liver diseases and cellular growth regulation. Understanding its structural role in the SSU processome provides insights into the pathophysiology of ribosomopathies and potential gene therapy approaches for NAIC. The protein's essential nature in basic cellular machinery suggests that any therapeutic modulation would require high specificity to avoid systemic toxicity.

Other names
UTP4CIRH1ANorth American Indian childhood cirrhosis proteinWD repeat-containing protein 4TEX292
02

Mechanism of action

None

03

Biological functions

Ribosome biogenesisrRNA processingt-UTP subcomplex assemblyOther
04

Disease associations

North American Indian Childhood Cirrhosis (NAIC)Other
05

Safety considerations

Essentiality for ribosome biogenesisPotential for systemic toxicity if inhibited
06

Biomarkers

CIRH1A mutation (c.1777C>T)R565W amino acid substitution

Beyond the preview

Go deeper on Cirhin (UTP4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cirhin (UTP4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call